Abstract:Background: Pituitary neuroendocrine tumors (PitNETs), which originate from the pituitary gland, account for 10%-15% of all intracranial neoplasms. Recent studies have indicated that enhancer RNAs (eRNAs) exert regulatory effects on tumor growth. However, the mechanisms underlying the eRNA-mediated tumorigenesis of PitNETs have not been elucidated. Methods: Normal pituitary and PitNETs tissues were used to identify the differentially expressed eRNAs (DEEs). Immune gene sets and hallmarks of cancer gene sets were quantified based on single sample gene set enrichment analysis (ssGSEA) algorithm using GSVA. The perspective of immune cells among all samples was calculated by the CIBERSORT algorithm. Moreover, the regulatory network composed of key DEEs, target genes of eRNAs, hallmarks of cancer gene sets, differentially expressed TF, immune cells and immune gene sets were constructed by Pearson correlation analysis. Small molecular anti-PitNETs drugs were explored by CMap analysis and the accuracy of the study was verified by in vitro and in vivo experiments, ATAC-seq and ChIP-seq. Results: In this study, data of 134 PitNETs and 107 non-tumorous pituitary samples were retrieved from a public database to identify differentially expressed genes. In total, 1128 differentially expressed eRNAs (DEEs) (494 upregulated eRNAs and 634 downregulated eRNAs) were identified. Next, the correlation of DEEs with cancer-related and immune-related gene signatures was examined to establish a co-expression regulatory network comprising 18 DEEs, 50 potential target genes of DEEs, 5 cancer hallmark gene sets, 2 differentially expressed transcription factors, 4 immune cell types, and 4 immune gene sets. Based on this network, the following four therapeutics for PitNETs were identified using Connectivity Map analysis: ciclopirox, bepridil, clomipramine, and alexidine. The growth-inhibitory effects of these therapeutics were validated using in vitro experiments. Ciclopirox exerted potential growth-inhibitory effects on PitNETs. Among the DEEs, GNLY, HOXB7, MRPL33, PRDM16, TCF7, and ZNF26 were determined to be potential diagnostic and therapeutic biomarkers for PitNETs. Conclusion: This study illustrated the significant influence of eRNAs on the occurrence and development of PitNETs. By constructing the co-expression regulation network, GNLY, HOXB6, MRPL33, PRDM16, TCF7, and ZNF26 were identified as relatively significant DEEs which were considered as the novel biomarkers of diagnosis and treatment of PitNETs. This study demonstrated the roles of eRNAs in the occurrence and development of PitNETs and revealed that ciclopirox was a potential therapeutic for pituitary adenomas.

Identification of Differentially Coexpressed Genes in Gonadotrope Tumors and Normal Pituitary Using Bioinformatics Methods

Bioinformatics Analysis of Gene Expression Profile of Serous Ovarian Carcinomas to Screen Key Genes and Pathways

Identification of Potential Biomarkers with Diagnostic Value in Pituitary Adenomas Using Prediction Analysis for Microarrays Method

Large-Scale Screening for Genes Related to Pathogenesis of Pituitary Carcinoma

Identification and Analysis of Genes Associated with Papillary Thyroid Carcinoma by Bioinformatics Methods

Pathogenesis analysis of pituitary adenoma based on gene expression profiling.

Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors

Identification Of Differentially Expressed Genes Between Mucinous Adenocarcinoma And Other Adenocarcinoma Of Colorectal Cancer Using Bioinformatics Analysis

Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis

Identification of Human Prolactinoma Related Genes by DNA Microarray.

Analysis of Differentially Expressed Genes in Ductal Carcinoma with DNA Microarray.

Identification of Differentially Expressed Genes and Signaling Pathways in Papillary Thyroid Cancer: a Study Based on Integrated Microarray and Bioinformatics Analysis.

Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis

The Gene Expression Profiles of Pituitary Adenomas Studied by Cdna Microarray

Differential proteomic expression in non-functional pituitary neuroendocrine tumours and pituitary glands

Screening and identification of key biomarkers and related transcription factors in ovarian cancer by integrated bioinformatics analysis

Analysis of Differentially Expressed Genes Based on Microarray Data of Glioma.

High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.

Identification of Differentially Expressed Key Genes Between Glioblastoma and Low-Grade Glioma by Bioinformatics Analysis.

Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis

Identification and Validation of Core Genes Involved in the Development of Papillary Thyroid Carcinoma via Bioinformatics Analysis